PayPal Holdings, Inc. - 2PP.DE

2PP.DE Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
2PP.DE	0.2	-1.0	2.8	13.2	59.3	45.1	-39.8	-18.2	128.6	128.6
S&P 500	-1.8	-1.5	0.4	3.2	9.8	21.6	38.5	84.7	195.2	33829.5

Compare 2PP.DE with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	2PP.DE
name	PayPal Holdings, Inc.
price	85.48
changes percentage	0.1523
change	0.13
day low	82.6
day high	85.57
year high	88.29
year low	52.01
market cap	85697119200
price avg 50	84.1024
price avg 200	68.4605
exchange	XETRA
volume	77984
avg volume	25601
open	83.5
previous close	85.35
eps	4.01
pe	21.32
earnings announcement	2025-02-05T10:59:00.000+0000
shares outstanding	1002540000
timestamp	2025-01-27 16:35:54

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 59.3%

Overall Quarterly Financial Health: 48.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	29771000000	27518000000	8.19
gross profit	13704000000	13773000000	-0.50
gross profit ratio	0.46	0.5	-8.03
research and development expenses	2973000000	3253000000	-8.61
operating expenses	8676000000	9729000000	-10.82
interest income	480000000	174000000	175.86
interest expense	347000000	304000000	14.14
ebitda	6830000000	5498000000	24.23
ebitdaratio	0.23	0.2	14.83
operating income	5028000000	3837000000	31.04
operating income ratio	0.17	0.14	21.12
net income	4246000000	2419000000	75.53
net income ratio	0.14	0.09	62.24
eps	3.85	2.06	86.89

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 29,771 million in 2023 from 27,518 million in 2022 representing a change of 8.19%. This indicates a sales growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 8,676 million in 2023 from 9,729 million in 2022 representing a change of -10.82%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 6,830 million in 2023 from 5,498 million in 2022 representing a change of 24.23%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 5,028 million in 2023 from 3,837 million in 2022 representing a change of 31.04%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 4,246 million in 2023 from 2,419 million in 2022 representing a change of 75.53%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 3.85 in 2023 from 3.85 in 2022 representing a change of 86.89%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 13,704 million in 2023 from 13,773 million in 2022 representing a change of -0.5%. This indicates a sales profitability decline, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 2,973 million in 2023 from 3,253 million in 2022 representing a change of -8.61%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	7847000000	7885000000	-0.48
gross profit	3654000000	3608000000	1.27
gross profit ratio	0.47	0.46	1.77
research and development expenses	746000000	718000000	3.90
operating expenses	2263000000	2170000000	4.29
interest income	183000000	165000000	10.91
interest expense	106000000	93000000	13.98
ebitda	1672000000	1755000000	-4.73
ebitdaratio	0.21	0.24	-10.35
operating income	1391000000	1325000000	4.98
operating income ratio	0.18	0.17	5.49
net income	1010000000	1128000000	-10.46
net income ratio	0.13	0.14	-10.03
eps	1	1.01	-0.99

Overall Score of Quarterly Income Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 7,847 million in 2024Q3 from 7,885 million in 2024Q2 representing a change of -0.48%. This indicates a sales shrinking, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 2,263 million in 2024Q3 from 2,170 million in 2024Q2 representing a change of 4.29%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 1,672 million in 2024Q3 from 1,755 million in 2024Q2 representing a change of -4.73%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Net Income: Net income decreased to 1,010 million in 2024Q3 from 1,128 million in 2024Q2 representing a change of -10.46%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1 in 2024Q3 from 1 in 2024Q2 representing a change of -0.99%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 3,654 million in 2024Q3 from 3,608 million in 2024Q2 representing a change of 1.27%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 746 million in 2024Q3 from 718 million in 2024Q2 representing a change of 3.9%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 1,391 million in 2024Q3 from 1,325 million in 2024Q2 representing a change of 4.98%. The increase in operating income indicates better operational performance and increased profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	82166000000	78717000000	4.38
total liabilities	61115000000	58443000000	4.57
total equity	21051000000	20274000000	3.83
cash and cash equivalents	9081000000	7776000000	16.78
short term investments	4976000000	3075000000	61.82
long term investments	3273000000	5018000000	-34.77
total current assets	62569000000	57517000000	8.78
total non current assets	19597000000	21200000000	-7.56
total current liabilities	48466000000	45101000000	7.46
total non current liabilities	12649000000	13342000000	-5.19
common stock	0	0	NaN
retained earnings	23200000000	18954000000	22.40
total debt	9676000000	10417000000	-7.11

Overall Score of Annual Balance Sheet

0.78 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 82,166 million in 2023 from 78,717 million in 2022 representing a change of 4.38%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 21,051 million in 2023 from 20,274 million in 2022 representing a change of 3.83%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 9,081 million in 2023 from 7,776 million in 2022 representing a change of 16.78%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 4,976 million in 2023 from 3,075 million in 2022 representing a change of 61.82%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 62,569 million in 2023 from 57,517 million in 2022 representing a change of 8.78%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 23,200 million in 2023 from 18,954 million in 2022 representing a change of 22.4%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 9,676 million in 2023 from 10,417 million in 2022 representing a change of -7.11%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 61,115 million in 2023 from 58,443 million in 2022 representing a change of 4.57%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 48,466 million in 2023 from 45,101 million in 2022 representing a change of 7.46%. This indicates a higher short-term debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	83511000000	84016000000	-0.60
total liabilities	63337000000	63394000000	-0.09
total equity	20174000000	20622000000	-2.17
cash and cash equivalents	7272000000	7701000000	-5.57
short term investments	4646000000	5912000000	-21.41
long term investments	4282000000	4653000000	-7.97
total current assets	62673000000	62972000000	-0.47
total non current assets	20838000000	21044000000	-0.98
total current liabilities	50268000000	50713000000	-0.88
total non current liabilities	13069000000	12681000000	3.06
common stock	0	0	NaN
retained earnings	26226000000	25216000000	4.01
total debt	9976000000	9727000000	2.56

Overall Score of Quarterly Balance Sheet

0.33 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 83,511 million in 2024Q3 from 84,016 million in 2024Q2 representing a change of -0.6%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 20,174 million in 2024Q3 from 20,622 million in 2024Q2 representing a change of -2.17%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 7,272 million in 2024Q3 from 7,701 million in 2024Q2 representing a change of -5.57%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 4,646 million in 2024Q3 from 5,912 million in 2024Q2 representing a change of -21.41%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 62,673 million in 2024Q3 from 62,972 million in 2024Q2 representing a change of -0.47%. This indicates a worsen liquidity position.

  Total Debt: Total Debt increased to 9,976 million in 2024Q3 from 9,727 million in 2024Q2 representing a change of 2.56%. This indicates an increase in overall debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 63,337 million in 2024Q3 from 63,394 million in 2024Q2 representing a change of -0.09%. This indicates a decrease in overall liabilities.

  Total Current Liabilities: Total Current Liabilities decreased to 50,268 million in 2024Q3 from 50,713 million in 2024Q2 representing a change of -0.88%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 26,226 million in 2024Q3 from 25,216 million in 2024Q2 representing a change of 4.01%. This indicates an accumulated profits.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	2678000000	1127000000	137.62
operating cash flow	4843000000	5813000000	-16.69
free cash flow	4220000000	5107000000	-17.37
capital expenditure	-623000000	-706000000	11.76
depreciation and amortization	1072000000	1317000000	-18.60
deferred income tax	-668000000	-811000000	17.63
stock based compensation	1475000000	1261000000	16.97
accounts payables	7000000	-35000000	120.00
inventory	-19000000	0	NaN
acquisitions net	466000000	0	NaN
investments in property plant and equipment	-623000000	-706000000	11.76
net cash used for investing activites	752000000	-3421000000	121.98
debt repayment	475000000	1789000000	-73.45
common stock issued	127000000	143000000	-11.19
common stock repurchased	-5002000000	-4199000000	-19.12
dividends paid	0	0	NaN
net cash used provided by financing activities	-2993000000	-1110000000	-169.64
cash at end of period	21834000000	19156000000	13.98
accounts receivables	-114000000	-163000000	30.06
cash at beginning of period	19156000000	18029000000	6.25

Overall Score of Annual Cashflow Statement

0.25 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 2,678 million in 2023 from 1,127 million in 2022 representing a change of 137.62%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Accounts Payables: The absolute value of Accounts Payables decreased to 7 million in 2023 from 35 million in 2022 representing a change of 120.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 4,843 million in 2023 from 5,813 million in 2022 representing a change of -16.69%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 4,220 million in 2023 from 5,107 million in 2022 representing a change of -17.37%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -623 million in 2023 from -706 million in 2022 representing a change of 11.76%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to -668 million in 2023 from -811 million in 2022 representing a change of 17.63%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 1,475 million in 2023 from 1,261 million in 2022 representing a change of 16.97%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to -114 in 2023 from -163 million in 2022 representing a change of 30.06%. This suggests that the company is less capable of collecting payments from its customers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	1614000000	1525000000	5.84
free cash flow	1445000000	1368000000	5.63
capital expenditure	-169000000	-157000000	-7.64
depreciation and amortization	255000000	263000000	-3.04
deferred income tax	-21000000	-23000000	8.70
stock based compensation	284000000	298000000	-4.70
accounts receivables	-51000000	121000000	-142.15
accounts payables	35000000	11000000	218.18
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	-169000000	-157000000	-7.64
net cash used for investing activites	2799000000	-4647000000	160.23
debt repayment	132000000	1247000000	-89.41
common stock issued	0	55000000	-100.00
common stock repurchased	-1776000000	-1501000000	-18.32
dividends paid	0	0	NaN
net cash used provided by financing activities	-2529000000	200000000	-1364.50
net change in cash	2076000000	-2917000000	171.17
cash at end of period	21434000000	19358000000	10.72
cash at beginning of period	19358000000	22275000000	-13.10

Overall Score of Quarterly Cashflow Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 2,076 million in 2024Q3 from -2,917 million in 2024Q2 representing a change of 171.17%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 1,614 million in 2024Q3 from 1,525 million in 2024Q2 representing a change of 5.84%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 1,445 million in 2024Q3 from 1,368 million in 2024Q2 representing a change of 5.63%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -169 million in 2024Q3 from -157 million in 2024Q2 representing a change of -7.64%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 284 million in 2024Q3 from 298 million in 2024Q2 representing a change of -4.7%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Receivables: Accounts Receivables decreased to -51 million in 2024Q3 from 121 million in 2024Q2 representing a change of -142.15%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to -21 million in 2024Q3 from -23 million in 2024Q2 representing a change of 8.7%. This indicates that the company's tax liability for future periods has increased.

  Accounts Payables: The absolute value of Accounts Payables increased to 35 million in 2024Q3 from 11 million in 2024Q2 representing a change of 218.18%. This indicates that the company has increased its outstanding obligations to its suppliers.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	26.99	23.85	13.19
net income per share	3.85	2.1	83.64
operating cash flow per share	4.39	5.04	-12.83
free cash flow per share	3.83	4.43	-13.55
cash per share	12.74	9.4	35.54
book value per share	19.09	17.57	8.63
tangible book value per share	8.6	7.17	19.93
shareholders equity per share	19.09	17.57	8.63
interest debt per share	9.09	9.29	-2.19
market cap	67735230000	82187880000	-17.58
enterprise value	68330230000	84828880000	-19.45
pe ratio	15.95	33.98	-53.05
price to sales ratio	2.28	2.99	-23.82
pocfratio	13.99	14.14	-1.08
pfcf ratio	16.05	16.09	-0.26
pb ratio	3.22	4.05	-20.63
ptb ratio	3.22	4.05	-20.63
ev to sales	2.3	3.08	-25.55
enterprise value over ebitda	10.0	17.01	-41.19
ev to operating cash flow	14.11	14.59	-3.32
ev to free cash flow	16.19	16.61	-2.52
earnings yield	0.06	0.03	112.98
free cash flow yield	0.06	0.06	0.26
debt to equity	0.46	0.51	-10.54
debt to assets	0.12	0.13	-11.01
net debt to ebitda	0.09	0.53	-83.55
current ratio	1.29	1.28	1.23
interest coverage	14.49	12.62	14.80
income quality	1.14	2.4	-52.54
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.07	0.08	-9.33
research and ddevelopement to revenue	0.1	0.12	-15.52
intangibles to total assets	0.14	0.15	-7.66
capex to operating cash flow	0.13	0.12	5.92
capex to revenue	0.02	0.03	-18.43
capex to depreciation	0.58	0.54	8.41
stock based compensation to revenue	0.05	0.05	3.68
graham number	40.66	28.79	41.24
roic	0.12	0.08	42.73
return on tangible assets	0.06	0.04	65.87
graham net net	-11.98	-12.21	1.90
working capital	14103000000	12416000000	13.59
tangible asset value	9488000000	8277000000	14.63
net current asset value	1454000000	-926000000	257.02
invested capital	27154000000	26143000000	3.87
average receivables	45047500000	43222500000	4.22
average payables	41107000000	39589000000	3.83
average inventory	-223000000	8500000	-2723.53
days sales outstanding	557.07	592.35	-5.96
days payables outstanding	955.81	1065.92	-10.33
days of inventory on hand	-10.52	0.45	-2429.93
receivables turnover	0.66	0.62	6.33
payables turnover	0.38	0.34	11.52
inventory turnover	-34.7	808.53	-104.29
roe	0.2	0.12	69.05
capex per share	0.56	0.61	-7.68

• Positive

  ROE: Return on Equity (ROE) increased to 0.20 on 2023-12-31 from 0.12 on 2022-12-31, representing a change of 69.05%. Suggesting the company has been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 1.29 on 2023-12-31 from 1.28 on 2022-12-31, representing a change of 1.23%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.46 on 2023-12-31 from 0.51 on 2022-12-31, representing a change of -10.54%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 15.95 on 2023-12-31 from 33.98 on 2022-12-31, representing a change of -53.05%. Indicating a decrease in the relative valuation of the company's stock.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
2PP.DE
calendar year	2024	2024	NaN
revenue per share	7.73	7.55	2.46
net income per share	1.0	1.08	-8.08
operating cash flow per share	1.59	1.46	8.65
free cash flow per share	1.42	1.31	8.44
cash per share	11.74	13.07	-10.14
book value per share	19.88	19.79	0.43
tangible book value per share	8.66	9.02	-4.09
shareholders equity per share	19.88	19.79	0.43
interest debt per share	9.93	12.49	-20.48
market cap	79200450000	60238020000	31.48
enterprise value	81904450000	65457020000	25.13
pe ratio	19.6	13.35	46.84
price to sales ratio	10.09	7.66	31.73
pocfratio	49.07	39.5	24.23
pfcf ratio	54.81	44.03	24.47
pb ratio	3.93	2.92	34.40
ptb ratio	3.93	2.92	34.40
ev to sales	10.44	8.33	25.37
enterprise value over ebitda	48.99	39.17	25.05
ev to operating cash flow	50.75	42.92	18.23
ev to free cash flow	56.68	47.85	18.46
earnings yield	0.01	0.02	-31.90
free cash flow yield	0.02	0.02	-19.66
debt to equity	0.49	0.63	-21.09
debt to assets	0.12	0.15	-22.34
net debt to ebitda	1.62	3.12	-48.22
current ratio	1.25	1.24	0.41
interest coverage	13.12	15.22	-13.75
income quality	1.6	1.35	18.20
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.07	0.07	-8.77
research and ddevelopement to revenue	0.1	0.09	4.10
intangibles to total assets	0.14	0.13	2.13
capex to operating cash flow	0.1	0.1	1.71
capex to revenue	0.02	0.02	7.85
capex to depreciation	0.66	0.6	11.02
stock based compensation to revenue	0.04	0.04	-8.80
graham number	21.1	21.96	-3.92
roic	0.03	0.03	-5.90
return on tangible assets	0.01	0.02	-9.62
graham net net	-16.16	-15.09	-7.05
working capital	12405000000	12259000000	1.19
tangible asset value	8785000000	9403000000	-6.57
net current asset value	-664000000	-422000000	-57.35
invested capital	25290000000	25540000000	-0.98
average receivables	46048000000	23255000000	98.01
average payables	41603500000	20984000000	98.26
average inventory	0	-2209000000	100.00
days sales outstanding	535.55	519.74	3.04
days payables outstanding	887.49	799.36	11.02
days of inventory on hand	0	0	NaN
receivables turnover	0.17	0.17	-2.95
payables turnover	0.1	0.11	-9.93
inventory turnover	0	0	NaN
roe	0.05	0.05	-8.47
capex per share	0.17	0.15	10.51

• Negative

  ROE: Return on Equity (ROE) decreased to 0.05 on 2024-09-30 Q3 from 0.05 on 2024-06-30 Q2, representing a change of -8.47%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 19.60 on 2024-09-30 Q3 from 13.35 on 2024-06-30 Q2, representing a change of 46.84%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.25 on 2024-09-30 Q3 from 1.24 on 2024-06-30 Q2, representing a change of 0.41%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.49 on 2024-09-30 Q3 from 0.63 on 2024-06-30 Q2, representing a change of -21.09%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 98.32 which is higher than current price 85.48, indicates the company may be undervalued.